| book details |

Biotechnology and Cancer Therapeutics

Edited by Manisha Nigam, Edited by Abhay Prakash Mishra

This book is currently unavailable. Enquire to check if we can source a used copy

| enquire |

| book description |

This book explores new ground in the field of cutting-edge cancer treatment modalities by presenting contemporary biotechnological developments as a component of cancer targeting techniques. It addresses the application of modern technologies in cancer detection, targeting, and the development of therapeutic strategies across fifteen comprehensive chapters. The book emphasizes the advantages of molecular techniques for cancer therapies, such as molecular diagnosis, cell and gene therapy, and immunotherapy, with a dedicated chapter on personalized cancer therapy to critically analyze the progression toward precision strategies. Â The chapters cover topics such as molecular biomarkers, microRNAs, and the potential of nanomedicine in cancer treatment. The authors provide expert analysis on the latest research, offering insights into the outcomes of scientific and clinical trials. Readers will also discover discussions on drug resistance, novel molecular targets, and the integration of biotechnology in drug discovery and development. Particular attention is given to the role of epigenetics and RNA interference in cancer therapy, as well as the challenges and future prospects of personalized medicine. This book is designed specifically for oncologists, cancer biologists, researchers, academicians, and students interested in understanding the most cutting-edge biotechnological aspects of cancer therapeutics. It offers a comprehensive overview of cancer prevention, therapeutics, and treatments through the perspectives of technology, medicine, and alternative therapies. Researchers in the field of biotechnology and cancer therapy will find this book invaluable for its detailed discussions and insights into the latest advancements. It serves as a crucial tool for those working in this area, providing a valuable resource for understanding the complexities of cancer therapies and fostering progress in the field.Â